Overview

The International Photodynamic Association (IPA) was founded in 1986 to support and endorse the scientific advancement and clinical development of photodynamic therapy (PDT), photoimmunotherapy (PIT), and photodiagnosis (PD). With members and associates from over 30 countries, the IPA represents a truly global community consisting of prominent international scientists, clinical and translational researchers, healthcare professionals and students across academic, hospital, government and private sector organizations. The IPA promotes the study of diagnosis and treatment using light-activated photosensitizers and disseminates scientific information to its members, the research community, and to the community at large. The IPA organizes a Biennial World Congress, providing members and non-members a unique opportunity to share and learn more about global developments and research in photodynamic therapy and photodiagnosis.